Lower Merrimack Valley Regional Collaborative Announces Additional COVID-19 Vaccine Clinics in January

Tuesday January 11, 2022

WEST NEWBURY — The Lower Merrimack Valley Regional Collaborative is pleased to announce that it will host additional community COVID-19 vaccination clinics for all eligible age groups this month with first, second and booster doses available on Monday January 17, 24 and 31, from 5 to 8:00 p.m. at the West Newbury Town Office Building Annex, 381 Main St., West Newbury.

Clinics will administer first, second and booster doses of all vaccines (Moderna, Pfizer-BioNTech, and Johnson & Johnson/Janssen) to all eligible age groups. First and second doses of the Pfizer-BioNTech Pediatric Vaccine — the same vaccine administered to adults but at a lower dosage — will be administered to those ages five to 11 with a signed consent form from a parent or guardian.

The CDC recommends anyone age five and older get the vaccine in order to stop the spread of COVID-19 as cases continue to rise following the Omicron variant.

The CDC recommends that those over the age of 18 who have completed a full Pfizer-BioNTech or Moderna regimen seek out a booster shot five months after their second dose, and that those who received a Janssen dose seek a booster shot two months after their initial vaccination. Individuals can check if they are eligible for a booster by visiting the eligibility tool at mass.gov/BoosterCheck.

Vaccines are free. Insurance is not required. Attendees will be required to wear masks and maintain physical distance in accordance with current Massachusetts guidelines regarding clinics. To make an appointment at the clinic visit https://home.color.com/vaccine/register/amesbury

The Lower Merrimack Valley Regional Collaborative comprises Amesbury, Georgetown, Groveland, Merrimac, Newbury, Newburyport, Rowley, Salisbury and West Newbury.

Support Local Businesses

Priced Right Junk Removal

Local Forecast

Subscribe To Receive Our Newspaper Every Wednesday Morning FREE

Join our mailing list to receive the latest news and newspaper within your emails.

You have Successfully Subscribed!